Lutz Heinemann

Glucose Management Indicator (GMI): A New Term for Estimating A1C From Continuous Glucose Monitoring

Richard M. Bergenstal, Roy W. Beck, Kelly L. Close et al. · Diabetes Care · 2018 · 630 citations · Full text

New Term, Artificial Pancreas, Obesity +17

Lower Within-Subject Variability of Insulin Detemir in Comparison to NPH Insulin and Insulin Glargine in People With Type 1 Diabetes

Tim Heise, Leszek Nosek, Birgitte Rønn et al. · Diabetes · 2004 · 618 citations · Full text

Real-time continuous glucose monitoring in adults with type 1 diabetes and impaired hypoglycaemia awareness or severe hypoglycaemia treated with multiple daily insulin injections (HypoDE): a multicentre, randomised controlled trial

Lutz Heinemann, Guido Freckmann, Dominic Ehrmann et al. · The Lancet · 2018 · 495 citations

Type 1, Diabetes Management, Health Policy +7

Home Use of an Artificial Beta Cell in Type 1 Diabetes

Hood Thabit, Martin Tauschmann, Janet M. Allen et al. · New England Journal of Medicine · 2015 · 447 citations · Full text

Consensus Recommendations for the Use of Automated Insulin Delivery Technologies in Clinical Practice

Moshe Phillip, Revital Nimri, Richard M. Bergenstal et al. · Endocrine Reviews · 2022 · 364 citations · Full text

Biomedical Engineering, Artificial Pancreas, Aid Systems +16